Asset Details
MbrlCatalogueTitleDetail
Risdiplam in Presymptomatic Spinal Muscular Atrophy
/ Age
/ Asymptomatic Diseases - therapy
/ Babies
/ Female
/ Genetics
/ Humans
/ Infant
/ Infants
/ Male
/ mRNA
/ Neuromuscular Agents - administration & dosage
/ Neuromuscular Agents - adverse effects
/ Neuromuscular Agents/administration & dosage/adverse effects
/ Nutritional Support - statistics & numerical data
/ Ostomy
/ Outpatient-Based Clinical Medicine
/ Patients
/ Proteins
/ Respiration, Artificial - statistics & numerical data
/ RNA Precursors/genetics/metabolism
/ Sciences de la santé humaine
/ Spinal Muscular Atrophies of Childhood - diagnosis
/ Spinal Muscular Atrophies of Childhood - drug therapy
/ Spinal Muscular Atrophies of Childhood - genetics
/ Spinal Muscular Atrophies of Childhood - mortality
/ Spinal Muscular Atrophies of Childhood/diagnosis/drug therapy/genetics/mortality
/ Survival
/ Survival of Motor Neuron 2 Protein